Health Care & Life Sciences » Pharmaceuticals | Guizhou Bailing Group Pharmaceutical Co. Ltd.

Guizhou Bailing Group Pharmaceutical Co. Ltd. | Ownership

Companies that own Guizhou Bailing Group Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
China Investment Corp. (Investment Management)
8,801,700
1.62%
0
0.04%
09/30/2017
Beijing Shen Zhou Mu Fund Management Ltd.
5,720,568
1.05%
1,444,968
56.62%
09/30/2017
China Asset Management Co., Ltd.
1,752,915
0.32%
-40,900
0.01%
12/31/2017
Huatai-PineBridge Fund Management Co., Ltd.
998,874
0.18%
209,800
0.03%
12/31/2017
Guotai Junan Allianz Fund Management Co., Ltd.
945,059
0.17%
-52,100
0.09%
12/31/2017
The Vanguard Group, Inc.
681,807
0.13%
0
0%
07/31/2018
GF Fund Management Co., Ltd.
680,950
0.13%
72,200
0.01%
12/31/2017
Harvest Fund Management Co., Ltd.
665,628
0.12%
-60,700
0.01%
07/27/2018
SWS MU Fund Management Co., Ltd.
455,911
0.08%
-116,500
0.02%
12/31/2017
E Fund Management Co., Ltd.
342,075
0.06%
9,400
0%
12/31/2017

About Guizhou Bailing Group Pharmaceutical Co.

View Profile
Address
Xihang Avenue
Anshun Guizhou 561000
China
Employees -
Website http://www.gzbl.com
Updated 07/08/2019
Guizhou Bailing Group Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicines. It offers medicines in the form of tablets, capsules, syrups, soft capsules, granules, pills, powder, sprays, creams, and injections. Its products are used for treatment of cardiovascular and cerebrovascular diseases, cough, common cold, and fever.